ArticleBMC immunology2026
Clinical and immunological factors associated with gastrointestinal involvement in common variable immunodeficiency: a real-world study.
Article in BMC immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastrointestinal (GI) involvement is a common and clinically significant manifestation of common variable immunodeficiency (CVID); however, its relationship with immunological parameters remains incompletely understood.
objectiveThis study aimed to evaluate the association between GI involvement and immunological markers, particularly serum immunoglobulin levels and B-cell subsets, and to assess their discriminative performance.
methodsIn this single-center retrospective study, 109 adult patients with CVID were included and categorized based on GI involvement. Clinical, endoscopic, histopathological, and immunological data were analyzed. Multivariable logistic regression analysis was performed to identify factors independently associated with GI involvement. Receiver operating characteristic (ROC) curve analysis was conducted to evaluate discriminative performance.
resultsGI involvement was present in 58.7% of patients. Patients with GI involvement had significantly lower serum IgA and IgM levels, as well as reduced percentages of CD19⁺CD27⁺IgD⁻ switched memory B cells. In multivariable analysis, low IgM levels (OR = 0.161, 95% CI: 0.041-0.633, p = 0.009) and decreased switched memory B-cell percentage (OR = 0.918, 95% CI: 0.855-0.986, p = 0.019) were independently associated with GI involvement. ROC analysis demonstrated good discriminative ability for serum IgM (AUC = 0.799, 95% CI: 0.708-0.889) and moderate discriminative performance for switched memory B cells (AUC = 0.695, 95% CI: 0.589-0.802). Endoscopic abnormalities were detected in 87.7% of evaluated patients, with inflammatory bowel disease-like patterns being the most common histopathological finding.
conclusionGI involvement is common in CVID and is independently associated with reduced IgM levels and decreased switched memory B cells, suggesting a potential role of impaired B-cell maturation in its pathophysiology. These findings may help identify patients at higher risk and support the clinical utility of immunophenotyping. Prospective multicenter studies are needed to validate these findings and to establish clinically relevant cutoff values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.